Eleanor Williams - Concepedia

Author

Eleanor Williams

Also Known As

E. Williams, Eleanor M. Williams, Eleanor P. Williams, Eleanor Williams, Jasmin Cara Aschenbrenner, Matthew J. Welland, Sarah Howles, Williams, E., Williams, Eleanor

Publications

992

Citations

H-Index

Concepts

All Affiliations

University of Oxford Genomics (United Kingdom)University of Toronto University College London Institute of Cancer Research

About

Eleanor Williams is an author at University of Oxford specializing in medicine, pathology, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	378
2	Natural Sciences	2	2	186
3	Health Sciences	1	1	64
4	Biochemistry	1	1	22
5	Cell Biology	1	1	64

Eleanor Williams

Publications

696

Citations

H-Index

Page 1

	Year	Citations
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage Xueqing Zou, Gene Ching Chiek Koh, Arjun S. Nanda, Nature Cancer Genome InstabilityMedicineGeneticsNatural SciencesMolecular Biology	2021	164
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas Jérôme Fortin, Ruxiao Tian, Ida Zarrabi, Cancer Cell	2020	91
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Ramita Dewan, Ruth Chia, Jinhui Ding, Neuron Amyotrophic Lateral SclerosisAlzheimer's DiseasePathologyDegenerative DiseaseFrontotemporal Dementia	2020	79
Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation Daniel Horbelt, Jan H. Boergermann, A. Chaikuad, Journal of Biological Chemistry	2014	72
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva Eleanor Williams, Jana Bagarova, Georgina Kerr, JCI Insight OsteopathyBone RepairPathologyOsteogenesisSurgery	2021	64
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva‐Derived Endothelial Cells Gonzalo Sánchez‐Duffhues, Eleanor Williams, Pascal Benderitter, JBMR Plus	2019	44
Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases Celia L. Gregson, Lawrie Wheeler, Sarah Hardcastle, Journal of Bone and Mineral Research	2015	41
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease Laura R. Claus, Chuan Chen, Jennifer L. Stallworth, Kidney International UrologyMendelian DisorderGenetic DisorderSerine/threonine Kinase Nek8Medicine	2023	33
Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure–Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept Liam Hudson, James Mui, Santiago Vázquez, Journal of Medicinal Chemistry	2018	32
Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma Deeba Ensan, David Smil, Carlos Zepeda‐Velázquez, Journal of Medicinal Chemistry	2020	28

Page 1